Given the fact that highly activated cytotoxic CD16+ T cells, capable of immune complex-mediated, TCR-independent cytotoxicity, are recruited in severe COVID-19 [85], the selection of potential donors with high levels of plasma virus-neutralizing activity is especially important [86]. This evidence concerns the gene FCGR3A and COVID-19.